Chargement en cours...
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID‐19
In late 2019, a new coronavirus emerged in Wuhan Province, China, causing lung complications similar to those produced by the SARS coronavirus in the 2002–2003 epidemic. This new disease was named COVID‐19 and the causative virus SARS‐CoV‐2. The SARS‐CoV‐2 virus enters the airway and binds, by means...
Enregistré dans:
| Publié dans: | Drug Dev Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267340/ https://ncbi.nlm.nih.gov/pubmed/32356926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21679 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|